Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody.
Int Immunopharmacol. 2019 Dec;77:106002. doi: 10.1016/j.intimp.2019.106002. Epub 2019 Nov 8.
Int Immunopharmacol. 2019.
PMID: 31711939